{
    "title": "Russia's R-Pharm retools arthritis drug for COVID-19 patients in clinical trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8819433/Russias-R-Pharm-retools-arthritis-drug-COVID-19-patients-clinical-trial.html",
    "date": "2020-10-08",
    "keywords": [
        "drug",
        "covid19",
        "olokizumab",
        "samsonov",
        "trial",
        "alexander",
        "marrow",
        "rpharm",
        "development",
        "russia",
        "vaccine",
        "storm",
        "work",
        "use",
        "concern",
        "safety",
        "moscow",
        "company",
        "officer",
        "mikhail",
        "interview",
        "october",
        "november",
        "arthritis",
        "need",
        "ventilation",
        "developer",
        "marketing",
        "license",
        "sign",
        "lead",
        "race",
        "pandemic",
        "sputnikv",
        "month",
        "approval",
        "prescription",
        "light",
        "recruitment",
        "june",
        "class",
        "interleukin6",
        "overreacting",
        "virus",
        "bodys",
        "immune",
        "system",
        "cytokine",
        "practice",
        "antibody",
        "temperature",
        "oxygenation",
        "benefit",
        "dose",
        "injection",
        "hyperinflammation",
        "lung",
        "damage",
        "speed",
        "rollout",
        "government",
        "efficacy",
        "covid",
        "reporting",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}